Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia.
Woonbok ChungAndrew D KellyPatricia KropfHenry FungJaroslav JelinekXiang Yao SuGail J RobozHagop M KantarjianMohammad AzabJean-Pierre J IssaPublished in: Clinical epigenetics (2019)
NCT01261312 .